Importer of Controlled Substances Application: SpecGX, LLC, 28153 [2021-10995]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 99 / Tuesday, May 25, 2021 / Notices
Controlled substance
Thebaine ...............................
Oxymorphone .......................
Phenazocine .........................
Carfentanil .............................
Fentanyl ................................
Drug
code
9333
9652
9715
9743
9801
Schedule
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances for internal use or for sale to
its customers. The company plans to
manufacture small quantities of the
above-listed controlled substances as
radiolabeled compounds for
biochemical research. No other
activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–10996 Filed 5–24–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–838]
Importer of Controlled Substances
Application: SpecGX, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SpecGX, LLC. has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplemental Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 24, 2021. Such persons
may also file a written request for a
hearing on the application on or before
June 24, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:09 May 24, 2021
Jkt 253001
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 5, 2021,
SpecGX LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana ........................
Phenylacetone .................
Coca Leaves ...................
Thebaine ..........................
Opium, Raw .....................
Poppy Straw Concentrate
Tapentadol ......................
Drug
code
Schedule
7360
8501
9040
9333
9600
9670
9780
I
II
II
II
II
II
II
The company plans to import the
listed controlled substances for bulk
manufacture into Active Pharmaceutical
Ingredients (API) for distribution to its
customers. In reference to Tapentadol
(9780) and Thebaine (9333), the
company plans to import intermediate
forms of these controlled substances for
further manufacturing prior to
distribution to its customers. In
reference to drug code 7360
(Marihuana), the company plans to
import synthetic cannabinol. No other
activity for this drug is authorized for
this registration. Placement of these
codes onto the company’s registration
does not translate into automatic
approval of subsequent permit
applications to import controlled
substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend the
import of Food and Drug
Administration-approved or nonapproved finished forms for commercial
sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–10995 Filed 5–24–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1105–0008]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection; Claim
for Damage, Injury, or Death
AGENCY:
Civil Division, Department of
Justice.
ACTION:
60-Day notice.
The Civil Division,
Department of Justice (DOJ), will be
SUMMARY:
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
28153
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until July
26, 2021.
FOR FURTHER INFORMATION CONTACT:
Comments are encouraged and all
comments should reference the 8 digit
OMB number for the collection or the
title of the collection. If you have
questions concerning the collection,
please contact James G. Touhey, Jr.,
Director, Torts Branch, Civil Division,
U.S. Department of Justice, P.O. Box
888, Benjamin Franklin Station,
Washington, DC 20044, Telephone:
(202) 616–4400.
Written comments and/or suggestions
can also be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Room 10235, 725 17th Street
NW, Washington, DC 20503 or sent to
OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.
2. The Title of the Form/Collection:
Claim for Damage, Injury, or Death.
3. The agency form number, if any,
and the applicable component of the
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 86, Number 99 (Tuesday, May 25, 2021)]
[Notices]
[Page 28153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10995]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-838]
Importer of Controlled Substances Application: SpecGX, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: SpecGX, LLC. has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 24, 2021.
Such persons may also file a written request for a hearing on the
application on or before June 24, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 5, 2021, SpecGX LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147, applied to be registered as an importer of
the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana............................... 7360 I
Phenylacetone........................... 8501 II
Coca Leaves............................. 9040 II
Thebaine................................ 9333 II
Opium, Raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
bulk manufacture into Active Pharmaceutical Ingredients (API) for
distribution to its customers. In reference to Tapentadol (9780) and
Thebaine (9333), the company plans to import intermediate forms of
these controlled substances for further manufacturing prior to
distribution to its customers. In reference to drug code 7360
(Marihuana), the company plans to import synthetic cannabinol. No other
activity for this drug is authorized for this registration. Placement
of these codes onto the company's registration does not translate into
automatic approval of subsequent permit applications to import
controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2).
Authorization will not extend the import of Food and Drug
Administration-approved or non-approved finished forms for commercial
sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-10995 Filed 5-24-21; 8:45 am]
BILLING CODE P
